Clinical Trial Update: Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

View source ↗

Summary

A clinical trial compares sublingual misoprostol to intravenous oxytocin for active management of the third stage of labor to prevent postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Rasha Mohammed Mohammed Badawi | Conditions: Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol | Status: UNKNOWN